Literature DB >> 21513466

Distinct tissue formation by heterogeneous printing of osteo- and endothelial progenitor cells.

Natalja E Fedorovich1, Hans M Wijnberg, Wouter J A Dhert, Jacqueline Alblas.   

Abstract

The organ- or tissue-printing approach, based on layered deposition of cell-laden hydrogels, is a new technique in regenerative medicine suitable to investigate whether mimicking the anatomical organization of cells, matrix, and bioactive molecules is necessary for obtaining or improving functional engineered tissues. Currently, data on performance of multicellular printed constructs in vivo are limited. In this study we illustrate the ability of the system to print intricate porous constructs containing two different cell types--endothelial progenitors and multipotent stromal cells--and show that these grafts retain heterogeneous cell organization after subcutaneous implantation in immunodeficient mice. We demonstrate that cell differentiation leading to the expected tissue formation occurs at the site of the deposited progenitor cell type. While perfused blood vessels are formed in the endothelial progenitor cell-laden part of the constructs, bone formation is taking place in the multipotent stromal cell-laden part of the printed grafts.

Entities:  

Mesh:

Year:  2011        PMID: 21513466     DOI: 10.1089/ten.TEA.2011.0019

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  22 in total

1.  Bio-printing cell-laden Matrigel-agarose constructs.

Authors:  Rong Fan; Marine Piou; Evan Darling; Denis Cormier; Jun Sun; Jiandi Wan
Journal:  J Biomater Appl       Date:  2016-09-16       Impact factor: 2.646

2.  Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells.

Authors:  B Duan; E Kapetanovic; L A Hockaday; J T Butcher
Journal:  Acta Biomater       Date:  2013-12-12       Impact factor: 8.947

3.  3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels.

Authors:  Bin Duan; Laura A Hockaday; Kevin H Kang; Jonathan T Butcher
Journal:  J Biomed Mater Res A       Date:  2012-09-27       Impact factor: 4.396

Review 4.  Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases.

Authors:  Chiara Arrigoni; Mara Gilardi; Simone Bersini; Christian Candrian; Matteo Moretti
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

Review 5.  Stem Cell-Laden Hydrogel-Based 3D Bioprinting for Bone and Cartilage Tissue Engineering.

Authors:  Zhimin Yang; Ping Yi; Zhongyue Liu; Wenchao Zhang; Lin Mei; Chengyao Feng; Chao Tu; Zhihong Li
Journal:  Front Bioeng Biotechnol       Date:  2022-05-17

Review 6.  Printing of Three-Dimensional Tissue Analogs for Regenerative Medicine.

Authors:  Vivian K Lee; Guohao Dai
Journal:  Ann Biomed Eng       Date:  2016-04-11       Impact factor: 3.934

Review 7.  Recent advances in 3D bioprinting of musculoskeletal tissues.

Authors:  Tyler Potyondy; Jorge Alfredo Uquillas; Peyton J Tebon; Batzaya Byambaa; Anwarul Hasan; Maryam Tavafoghi; Heloise Mary; George E Aninwene; Ippokratis Pountos; Ali Khademhosseini; Nureddin Ashammakhi
Journal:  Biofabrication       Date:  2021-03-10       Impact factor: 9.954

Review 8.  Hydrogel scaffolds for tissue engineering: Progress and challenges.

Authors:  Ibrahim M El-Sherbiny; Magdi H Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2013-11-01

Review 9.  3D Printing: Advancement in Biogenerative Engineering to Combat Shortage of Organs and Bioapplicable Materials.

Authors:  Arpana Parihar; Vasundhara Pandita; Avinash Kumar; Dipesh Singh Parihar; Nidhi Puranik; Tapas Bajpai; Raju Khan
Journal:  Regen Eng Transl Med       Date:  2021-07-02

10.  Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats.

Authors:  Michelle T Poldervaart; Huanan Wang; Johan van der Stok; Harrie Weinans; Sander C G Leeuwenburgh; F Cumhur Öner; Wouter J A Dhert; Jacqueline Alblas
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.